{
  "meta": {
    "disclaimer": "Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.",
    "terms": "https://open.fda.gov/terms/",
    "license": "https://open.fda.gov/license/",
    "last_updated": "2026-03-18",
    "results": {
      "skip": 0,
      "limit": 1,
      "total": 1
    }
  },
  "results": [
    {
      "status": "Terminated",
      "city": "Lumberton",
      "state": "NJ",
      "country": "United States",
      "classification": "Class II",
      "openfda": {},
      "product_type": "Drugs",
      "event_id": "84583",
      "recalling_firm": "AAA Pharmaceutical, Inc.",
      "address_1": "681 Main St",
      "address_2": "N/A",
      "postal_code": "08048-5013",
      "voluntary_mandated": "Voluntary: Firm initiated",
      "initial_firm_notification": "Letter",
      "distribution_pattern": "Product was distributed to one consignee who may have distributed the product further to their retail stores.",
      "recall_number": "D-0645-2020",
      "product_description": "Ranitidine 150 mg tablets, 24 count bottles, NDC 37808-196-01.",
      "product_quantity": "34,272 (24-count bottles)",
      "reason_for_recall": "CGMP Deviations: Impurity N-nitrosodimethylamine (NDMA) found in API",
      "recall_initiation_date": "20191226",
      "center_classification_date": "20200106",
      "termination_date": "20210310",
      "report_date": "20200115",
      "code_info": "P134458, Sept 2020  P134943, Aug 2020  P135840, Aug, 2020  P136622, April 2021  P136871, April 2021  P137347, April 2021  P137424, April 2021"
    }
  ]
}